Asset Details
- Identifier:
- pdi2249-fig-0001
- Description:
- Mechanism of action of cangrelor. Cangrelor reversibly binds to the ADP (adenosine diphosphate) binding site. Other P2Y12 inhibitors are also included for comparison. Ticagrelor binds to an alternative site. Prasugrel and clopidogrel are prodrugs
- License:
- Rights Managed
- Rights Holder:
- John Wiley & Sons, Inc.
- License Rights Holder:
- Copyright © 2019 John Wiley & Sons, Ltd
- Asset Type:
- Image
- Asset Subtype:
- Image Orientation:
- Landscape
- Image Dimensions:
- 2128 x 1499
- Image File Size:
- 452 KB
- Creator:
- Arnav Katira, MBBS, BSc, Ravish Katira, MBBS, MD, DM, FRCP
- Credit:
- Katira, A., & Katira, R. (2019). Cangrelor. Practical Diabetes, 36(6), 222-223a..
- Collection:
- Keywords:
- Restrictions:
- Property Release:
- No
- Model Release:
- No
- Purchasable:
- Yes
- Sensitive Materials:
- No
- Article Title:
- Cangrelor
- Article Authors:
- Arnav Katira, MBBS, BSc, Ravish Katira, MBBS, MD, DM, FRCP
- Article Copyright Year:
- 2019
- Publication Title:
- Practical Diabetes
- Publication Volume:
- 36
- Publication Issue:
- 6
- Publication Date:
- 11/01/2019
- DOI:
Click on image to enlarge
